Updated: Jun 21, 2026

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression
Published on: March 17, 2020
Terry W Moody1, Christopher Switzer, Wilmarie Santana-Flores
1National Cancer Institute, Office of the Director, Center for Cancer Research, Bethesda, MD 20892-1500, USA. moodyt@mail.nih.gov
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Modified valproate and diclofenac, known as S-valproate and S-diclofenac, show promise in inhibiting non-small cell lung cancer (NSCLC) growth and reducing prostaglandin E2 levels. These compounds may be beneficial for NSCLC chemoprevention and therapy.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: